{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:29:56Z","timestamp":1780378196916,"version":"3.54.1"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"1051","license":[{"start":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T00:00:00Z","timestamp":1359072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory rheumatic diseases that may present to a variety of disciplines and specialities. The mainstay of treatment is glucocorticoids (steroids); together PMR and GCA now represent one of the most common reasons for medium-to-high dose, long-term glucocorticoid treatment in primary care. However, adverse effects of glucocorticoids are common in these patients. Management of both diseases involves balancing the symptoms and risks of the disease against the adverse effects and risks of glucocorticoids. The crucial first step in management is to make a firm, well-documented diagnosis, since once glucocorticoids are started they can mask the symptoms of a number of other diseases. Diagnosis however can be challenging and there are still substantial gaps in the evidence for treatment.<\/jats:p>","DOI":"10.1136\/postgradmedj-2012-131400","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T01:48:11Z","timestamp":1359164891000},"page":"284-292","source":"Crossref","is-referenced-by-count":8,"title":["Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips"],"prefix":"10.1093","volume":"89","author":[{"given":"Sarah Louise","family":"Mackie","sequence":"first","affiliation":[{"name":"Division of Rheumatic and Musculoskeletal Disease, NIHR-Leeds Musculoskeletal Research Unit, Chapel Allerton Hospital, University of Leeds , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin Thomas","family":"Pease","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,25]]},"reference":[{"key":"2023041906230181000_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.2009.177220","article-title":"Giant cell arteritis in Asians: a comparative study","volume":"95","author":"Pereira","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"2023041906230181000_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990\u20132001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib3","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984\u20131988","volume":"19","author":"Franzen","year":"1992","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib4","first-page":"2624","article-title":"Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings","volume":"27","author":"Haugeberg","year":"2000","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.60.4.367","article-title":"Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period","volume":"60","author":"Gonzalez-Gay","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ije\/18.4.836","article-title":"A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?","volume":"18","author":"Machado","year":"1989","journal-title":"Int J Epidemiol"},{"key":"2023041906230181000_bib8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2003.09.008","article-title":"Are polymyalgia rheumatica and giant cell arteritis the same disease?","volume":"33","author":"Cantini","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"2023041906230181000_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-129-5-199809010-00001","article-title":"Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis","volume":"129","author":"Rao","year":"1998","journal-title":"Ann Intern Med"},{"key":"2023041906230181000_bib14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ajo.2012.03.045","article-title":"Validity of the American College of Rheumatology Criteria for the diagnosis of giant cell arteritis","volume":"154","author":"Murchison","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"2023041906230181000_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/ard.2004.025296","article-title":"A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica","volume":"64","author":"Bird","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/art.10402","article-title":"Increased frequency of malignancy found in patients presenting with new-onset polymyalgic symptoms suggested to have polymyalgia rheumatica","volume":"47","author":"Haugeberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","article-title":"Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement","volume":"27","author":"Wilkinson","year":"1972","journal-title":"Arch Neurol"},{"key":"2023041906230181000_bib20","first-page":"700","article-title":"An undescribed form of arteritis of the temporal vessels","volume":"7","author":"Horton","year":"1932","journal-title":"Proc Staff Meet Mayo Clinic"},{"key":"2023041906230181000_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/qjmed\/15.57.47","article-title":"Temporal arteritis; a generalized vascular disease","volume":"15","author":"Cooke","year":"1946","journal-title":"Q J Med"},{"key":"2023041906230181000_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","article-title":"Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study","volume":"30","author":"Cantini","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"2023041906230181000_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.48.8.667","article-title":"Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica\/giant cell arteritis on presentation and during follow up","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000331059","article-title":"Plasma viscosity in giant cell arteritis","volume":"66","author":"Finke","year":"2011","journal-title":"Eur Neurol"},{"key":"2023041906230181000_bib26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/acr.20043","article-title":"Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis","volume":"62","author":"Garcia-Martinez","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 2","key":"2023041906230181000_bib27","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/513856","article-title":"Cytokines as endogenous pyrogens","volume":"179","author":"Dinarello","year":"1999","journal-title":"J Infect Dis"},{"key":"2023041906230181000_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF02208693","article-title":"Liver scan abnormalities in polymyalgia rheumatica\/giant cell arteritis","volume":"10","author":"Kyle","year":"1991","journal-title":"Clin Rheumatol"},{"key":"2023041906230181000_bib29","first-page":"1103","article-title":"Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis","volume":"26","author":"Breuer","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2023041906230181000_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-9071.2006.01186.x","article-title":"Giant cell arteritis","volume":"34","author":"Carroll","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"2023041906230181000_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"2023041906230181000_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA"},{"key":"2023041906230181000_bib33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00296-010-1690-0","article-title":"Reduction in jaw opening: a neglected symptom of giant cell arteritis","volume":"31","author":"Kraemer","year":"2011","journal-title":"Rheumatol Int"},{"key":"2023041906230181000_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.STR.17.2.325","article-title":"Temporal arteritis-like presentation of carotid atherosclerosis","volume":"17","author":"Venna","year":"1986","journal-title":"Stroke"},{"key":"2023041906230181000_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200301000-00001","article-title":"Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature","volume":"82","author":"Ruegg","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2023041906230181000_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00041327-200020040-00015","article-title":"Ophthalmic artery microembolism in giant cell arteritis","volume":"20","author":"Schauble","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"2023041906230181000_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2023041906230181000_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"2023041906230181000_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"2023041906230181000_bib40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib41","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib42","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","article-title":"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/rheumatology\/ker329","article-title":"Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study","volume":"51","author":"Ghinoi","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32831cec7b","article-title":"Imaging for large-vessel vasculitis","volume":"21","author":"Blockmans","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"2023041906230181000_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","article-title":"The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease","volume":"32","author":"Walter","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023041906230181000_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MD.0b013e3181a68ae2","article-title":"Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients","volume":"88","author":"Marie","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"2023041906230181000_bib48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2009.02.027","article-title":"Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases","volume":"116","author":"Zhou","year":"2009","journal-title":"Ophthalmology"},{"key":"2023041906230181000_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/art.33362","article-title":"Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis","volume":"64","author":"Restuccia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/00313020120038764","article-title":"Healed or quiescent temporal arteritis versus senescent changes in temporal artery biopsy specimens","volume":"33","author":"Cox","year":"2001","journal-title":"Pathology"},{"key":"2023041906230181000_bib51","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.23700","article-title":"Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?","volume":"58","author":"Chatelain","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib52","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780330804","article-title":"Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis","volume":"33","author":"Lie","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3899\/jrheum.080792","article-title":"Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis","volume":"36","author":"Breuer","year":"2009","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"Pt 1","key":"2023041906230181000_bib55","first-page":"125","article-title":"The classification and diagnosis of vasculitis in large and medium-sized blood vessels","volume":"22","author":"Lie","year":"1987","journal-title":"Pathol Annu"},{"key":"2023041906230181000_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","article-title":"Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis","volume":"37","author":"Narvaez","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"2023041906230181000_bib57","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"2023041906230181000_bib58","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jclinpath-2012-200870","article-title":"Does preoperative steroid treatment affect the histology in giant cell (cranial) arteritis?","volume":"65","author":"Bury","year":"2012","journal-title":"J Clin Pathol"},{"key":"2023041906230181000_bib59","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib60","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(95)93005-1","article-title":"Colour Doppler sonography to diagnose temporal arteritis","volume":"345","author":"Schmidt","year":"1995","journal-title":"Lancet"},{"key":"2023041906230181000_bib61","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2003","article-title":"Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis","volume":"8","author":"Karahaliou","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2023041906230181000_bib62","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/kes153","article-title":"Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis","volume":"51","author":"Hauenstein","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"1 Suppl 70","key":"2023041906230181000_bib63","first-page":"S34","article-title":"The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis","volume":"30","author":"De Miguel","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl 49","key":"2023041906230181000_bib64","first-page":"S76","article-title":"1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries","volume":"26","author":"Ghinoi","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2023041906230181000_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.0954-6820.1947.tb06591.x","article-title":"Arteritis temporalis (Horton) (a symptom of a generalised vascular disease): a survey and a case with glaucoma","volume":"128","author":"Andersen","year":"1947","journal-title":"Acta Med Scand"},{"key":"2023041906230181000_bib66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2023041906230181000_bib67","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib68","first-page":"1484","article-title":"A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients","volume":"27","author":"Chevalet","year":"2000","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis","volume":"47","author":"Hernandez-Rodriguez","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib70","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/rheumatology\/ker163","article-title":"Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis\u2013a prospective longitudinal study","volume":"50","author":"Visvanathan","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib71","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","article-title":"Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study","volume":"45","author":"De Silva","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib73","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/37.4.464","article-title":"No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study","volume":"37","author":"Schaufelberger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"2023041906230181000_bib74","first-page":"373","article-title":"Treatment of giant cell arteritis with cyclophosphamide pulses","volume":"232","author":"de Vita","year":"1992","journal-title":"J Intern Med"},{"key":"2023041906230181000_bib75","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/rheumatology\/kes127","article-title":"Role of oral cyclophosphamide in the treatment of giant cell arteritis","volume":"51","author":"Quartuccio","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"2023041906230181000_bib77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","article-title":"Tocilizumab: a novel therapy for patients with large-vessel vasculitis","volume":"51","author":"Salvarani","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib79","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"2023041906230181000_bib80","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/ard.2010.149351","article-title":"Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib81","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, takayasu arteritis) and polymyalgia rheumatica","volume":"64","author":"Unizony","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023041906230181000_bib82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.10071","article-title":"Therapeutic effects of acetylsalicylic acid in giant cell arteritis","volume":"46","author":"Weyand","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib83","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib84","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/ker265","article-title":"Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors","volume":"50","author":"Mackie","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3 Suppl 49","key":"2023041906230181000_bib86","first-page":"S57","article-title":"Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis","volume":"26","author":"Narvaez","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2023041906230181000_bib87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib88","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.20541","article-title":"Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis","volume":"51","author":"Garcia-Martinez","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib89","first-page":"681","article-title":"Polymyalgia rheumatica","volume":"54","author":"Boyle","year":"1961","journal-title":"Proc R Soc Med"},{"key":"2023041906230181000_bib90","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","article-title":"Myalgic syndrome with constitutional effects; polymyalgia rheumatica","volume":"16","author":"Barber","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib91","first-page":"1043","article-title":"Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation","volume":"32","author":"Pease","year":"2005","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib92","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ard.60.11.1021","article-title":"Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study","volume":"60","author":"Caporali","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 20","key":"2023041906230181000_bib93","first-page":"S53","article-title":"RS3PE syndrome: an overview","volume":"18","author":"Olivieri","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2023041906230181000_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/rheumatology\/ken343","article-title":"Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study","volume":"48","author":"Pease","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib95","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","article-title":"Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study","volume":"41","author":"Salvarani","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib96","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-77-6-845","article-title":"Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings","volume":"77","author":"Fauchald","year":"1972","journal-title":"Ann Intern Med"},{"key":"2023041906230181000_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/keq450","article-title":"Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis","volume":"51","author":"Camellino","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib98","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/41.1.46","article-title":"Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries","volume":"41","author":"Schmidt","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906230181000_bib99","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"4 Suppl 20","key":"2023041906230181000_bib101","first-page":"S34","article-title":"Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects","volume":"18","author":"Martinez-Taboada","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2023041906230181000_bib102","first-page":"1333","article-title":"Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis","volume":"26","author":"Proven","year":"1999","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib103","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/art.1780400930","article-title":"The diagnosis of polymyalgia rheumatica in patients with a low erythrocyte sedimentation rate: comment on the article by Helfgott and Kieval","volume":"40","author":"Cimmino","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2023041906230181000_bib104","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/jcp.41.11.1203","article-title":"International Committee for Standardization in Haematology (expert panel on blood rheology). Guidelines on selection of laboratory tests for monitoring the acute phase response","volume":"41","year":"1988","journal-title":"J Clin Pathol"},{"key":"2023041906230181000_bib105","first-page":"1837","article-title":"Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica","volume":"28","author":"McGonagle","year":"2001","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib106","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2474-12-94","article-title":"The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity","volume":"12","author":"Cimmino","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"2023041906230181000_bib107","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","article-title":"Patient-reported outcomes in polymyalgia rheumatica","volume":"39","author":"Matteson","year":"2012","journal-title":"J Rheumatol"},{"key":"2023041906230181000_bib108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","article-title":"Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)","volume":"47","author":"Delecoeuillerie","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib109","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"key":"2023041906230181000_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"van der Veen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"2023041906230181000_bib111","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","article-title":"Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial","volume":"146","author":"Salvarani","year":"2007","journal-title":"Ann Intern Med"},{"key":"2023041906230181000_bib112","doi-asserted-by":"crossref","first-page":"R176","DOI":"10.1186\/ar3140","article-title":"Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial","volume":"12","author":"Kreiner","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2023041906230181000_bib113","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3899\/jrheum.091185","article-title":"Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica","volume":"37","author":"Hagihara","year":"2010","journal-title":"J Rheumatol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1051\/284\/50017339\/postgradmedj-89-284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1051\/284\/50017339\/postgradmedj-89-284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:27:15Z","timestamp":1681885635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/89\/1051\/284\/6987440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,25]]},"references-count":113,"journal-issue":{"issue":"1051","published-online":{"date-parts":[[2013,1,25]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2012-131400","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,5]]},"published":{"date-parts":[[2013,1,25]]}}}